Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis

17 May 2020

Abstract excerpt

Visceral leishmaniasis (VL) is caused by a protozoan parasite Leishmania donovani mainly influencing the population of tropical and subtropical regions across the globe. The arsenal of drugs available is limited, and prolonged use of such drugs makes parasite to become resistant. Therefore, it is very imperative to develop a safe, cost-effective and inexpensive vaccine against VL. Although in recent years, many...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32418227
DOI: 10.1111/pim.12732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasisPMID 32418227Read ↗

Live attenuated Leishmania vaccines: a potential strategic alternativeSemantic proximity Read ↗

Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated LeishmaniaSemantic proximity Read ↗

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine CandidatesSemantic proximity Read ↗

Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasiteSemantic proximity Read ↗

Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.Semantic proximity Read ↗

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasisSemantic proximity Read ↗

Post-Genomics and Vaccine Improvement for LeishmaniaSemantic proximity Read ↗

Recent developments in leishmaniasisSemantic proximity Read ↗

Safety, immunogenicity, and efficacy of a gentamicin-attenuated Leishmania major vaccine in an open-label clinical vaccine trialSemantic proximity Read ↗

Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.